Literature DB >> 11890843

Magnetic resonance imaging in basilar artery occlusion.

Richard du Mesnil de Rochemont1, Tobias Neumann-Haefelin, Joachim Berkefeld, Matthias Sitzer, Heinrich Lanfermann.   

Abstract

CONTEXT: Acute basilar artery occlusion has particularly high mortality and morbidity.
OBJECTIVE: To determine the potential utility of advanced magnetic resonance imaging (MRI) methods, including diffusion-weighted imaging, for the early management of patients with basilar artery thrombosis.
DESIGN: Case series.
SETTING: Institute of Neuroradiology and Department of Neurology, Johann Wolfgang Goethe University, Frankfurt, Germany. PATIENTS: In 4 patients with occlusion of the basilar artery, MRI was performed, including T2-weighted and diffusion-weighted imaging (DWI) sequences and magnetic resonance angiography (MRA) in the short-term phase (<12 hours). Three patients underwent intra-arterial thrombolysis. Clinical outcome was obtained 10 days after symptom onset.
RESULTS: The MRA was performed 3.5 to 11.5 hours after symptom onset and showed basilar artery occlusion in all cases. The DWI revealed different patterns of ischemic lesions. In 2 patients, no or only small lesions could be identified; the remaining showed multiple and large lesions within the posterior circulation territory. Initial clinical status was severely impaired in all cases (Rankin scale score, 4-5). Thrombolysis was initiated in 3 patients, leading to successful recanalization in 2. Clinical outcome was favorable in the 2 patients with small DWI lesions and successful reperfusion (Rankin scale score, 2), whereas it was worse in those with large DWI lesions and persisting occlusion (death, persisting coma).
CONCLUSIONS: In critically ill patients with acute basilar occlusion, the extent of DWI lesion involvement can be highly variable. Small DWI lesions seem to be associated with a favorable outcome if reperfusion is achieved with thrombolysis. This could potentially be the case independent of time from symptom onset.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890843     DOI: 10.1001/archneur.59.3.398

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

Review 1.  [Diagnosis and therapy of basilar artery occlusion].

Authors:  T Pfefferkorn; T E Mayer; G Schulte-Altedorneburg; H Brückmann; G F Hamann; M Dichgans
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

Review 2.  Basilar artery occlusion.

Authors:  Tracey A Baird; Keith W Muir; Ian Bone
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Brain stem diffusion-weighted imaging lesion score: a potential marker of outcome in acute basilar artery occlusion.

Authors:  T-H Cho; N Nighoghossian; F Tahon; C Némoz; M Hermier; F Salkine; L Derex; P Trouillas; J-C Froment; F Turjman
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-03       Impact factor: 3.825

4.  Hyperdense basilar artery sign diagnoses acute posterior circulation stroke and predicts short-term outcome.

Authors:  Xiaoping Tan; Yang Guo
Journal:  Neuroradiology       Date:  2010-04-01       Impact factor: 2.804

5.  Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis.

Authors:  M Arnold; K Nedeltchev; G Schroth; R W Baumgartner; L Remonda; T J Loher; F Stepper; M Sturzenegger; B Schuknecht; H P Mattle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

6.  Favorable outcome from a locked-in state despite extensive pontine infarction by MRI.

Authors:  Edgar Andres Samaniego; Maarten G Lansberg; Michael DeGeorgia; Chitra Venkatasubramanian; Christine A C Wijman
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

7.  Cortical laminar necrosis detected by diffusion-weighted imaging in a dog suspected of having hypoglycemic encephalopathy.

Authors:  Ai Hori; Kenjirou Miyoshi; Wakako Seo; Ako Kakuta; Kiwamu Hanazono; Tetsuya Nakade
Journal:  J Vet Med Sci       Date:  2020-11-02       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.